SORT BY Relevancy
Tuesday, July 16, 2013 - 3:30 pm PST/6:30 pm EST
Our incredible special guest tonight is Dr. Christopher Ross who is Professor of Psychiatry, Neurology, Pharmacology and Neuroscience at Johns Hopkins University School of Medicine, Director of the Division of Neurobiology, Director of the NINDS-funded Baltimore Huntington’s Disease Center, and Director of the Huntington’s Disease Society of America Center of Excellence at Johns Hopkins.
Tonight PI Dr. Ross will give us an update on the HSG clinical trial PREQUEL. The results are in on this CoQ10 trial.
Tonight our special guests are Dr. Samuel Frank - Associate Professor of Neurology and co-Director of Neurology Resident Education at Boston University and is involved with many HSG studies and trials, and Dr. David Stamler - Chief Medical Officer at Auspex Pharmaceuticals.
Tonight we will be discussing First-HD, which is is a Phase III clinical research trial of an investigational drug called SD-809 Extended Release (ER) in persons who have a diagnosis of Huntington disease (HD). First-HD will be enrolling participants across North America (United States and Canada) who have been diagnosed with HD and who have never taken tetrabenazine (Xenazine ®, Nitoman ®). Participants will be involved in this trial for approximately 4 months.
Stay tuned and we look forward to having an awesome show tonight!
MONDAY, March 25, 2013
Our incredible special guest tonight is Dr. Neal Hermanowicz, Director of the Movement Disorders Program at the University of California at Irvine.
Dr. Hermanowicz is engaged foremost in patient care. He is a member of the Parkinson’s Study Group, The Huntington’s Study Group, the Dystonia Study Group, and the Multiple Systems Atrophy Study Group. Dr. Hermanowicz has been involved in numerous clinical trials and research in the area of movement disorders.
UC Irvine Medical Center’s Movement Disorders Services is a multidisciplinary practice that includes neurology, neurosurgery, nursing, physical therapy and nutritional counseling. Dr. Neal Hermanowicz, director, emphasizes that UC Irvine’s movement disorders specialists take a case management approach, which promotes communication among all the members of the team. This has a lot of benefits for patients with complex disorders like Parkinson’s disease, Hermanowicz says.
MONDAY, MARCH 26, 2012 Reach2HD is a Huntington's disease research trial sponsored by the Huntington's Study Group and Prana Biotechnology to study whether PBT2 (an investigational drug) is safe and effective and to determine if its effect on cognition and other symptoms including movement and overall function. Study requirements include 8 in-person visits over 6 months and examinations at no cost to you. If you have early to mid-stage Huntington's disease, are at lease 25 years ol
MONDAY, NOVEMBER 12, 2012 (3:30 pm PST/6:30 pm EST) We are excited to present a Reach2HD update from the following amazing individuals: Dr. Martha Nance is the Director of the HD COE. She is a co-author of “The Physician’s Guide to HD” and “The Juvenile HD Handbook”, and a past member of the Executive Committee of the Huntington Study Group. She is a member of the Steering Committee of Predict-HD and Enroll-HD, and has been a participant in many HD
PRE-RECORDED Jody Goldstein has a very long list of accomplishments: BS in Biology from the University of California, San Diego (UCSD), 10 years as coordinator for the UCSD Huntington's Disease Clinical Research Center (HDCRC), Genetically Handicapped Persons Program (GHPP), facilitator for the San Diego Huntington's Disease Support Group and serves as Study Coordinator for more than 18 Huntington's disease clinical studies, 21 publications in peer reviewed journals... the list goe
MONDAY, June 25, 2012 - 3:30 pm PST/6:30 pm EST Tonight - an update from our amazing Huntington Study Group (HSG) Reach2HD clinical trial Principal Investigator (PI) Dr. Ray Dorsey and Dr. Caroline Herd, Chief Development Consultant from Prana Biotechnology. Reach2HD is a study to discover whether PBT2 (an investigational drug) is safe and effective and to determine PBT2's effect on cognition (thinking abilities) and other symptoms including movement and overall functioning.
Monday, April 30, 2012 at 3:30 pm PST/6:30 pm EST Dr. Michael Geschwind is Associate Professor of Neurology and the Michael J. Homer Chair in Neurology. He received his MD and PhD in neuroscience through the National Institutes of Health-sponsored Medical Scientist Training Program at the Albert Einstein College of Medicine in New York. He completed his internship in internal medicine at the University of California, Los Angeles Medical Center, his neurology residency at the Johns Hopkins Univ
Monday, December 19, 2011 - Our incredible special guest is Dr. Christopher Ross, PI for the HSG sponsored PREQUEL Coenzyme Q10 study. Dr. Ross is Professor of Psychiatry, Neurology and Neurosciences at Johns Hopkins. In their study of neuropsychiatric disorders, Dr. Ross and his research team focus on Huntington's disease and Parkinson's disease, and use insights from these disorders to approach more complex diseases such as schizophrenia. They use biophysical and biochemical tec
Monday, October 24, 2011 - Our incredible special guest is Dr. LaVonne Goodman from HD Drug Works. Though the HDSA has provided the "A Physicians Guide to the Management of Huntington's Disease" for more than a decade (3rd edition recently available), there have been no published guides that have been peer-reviewed by physician leaders from the EHDN or HSG. Fortunately over the last 3 years both groups have spearheaded efforts within working-group committees to establish HD
In this episode I will give you an introduction into my infertility journey. I will cover trying to concieve (TTC) naturally and natural remedies I tried to increase my fertility. Then I will move on to my journey with my RE (Reproductive Endocrinologist) which includes fertility testing, HSG, clomid, laparoscopy, endometriosis and ivf (in vitro fertilization).
Monday, June 6, 2011 – Our incredible special guest is Steven Hersch, MD, PhD, Professor of Neurology at Massachusetts General Hospital and Harvard Medical School; Director, Laboratory of Neurodegeneration and Neurotherapeutics, MassGeneral Institute for Neurodegeneration; Director, New England HDSA Center of Excellence for Huntington’s Disease at MGH; Co-chair, Huntington Study Group; Principal Investigator of the CREST-E study; and Principal Investigator of the REVEAL-HD study. &
Join Host Live Chats
- YusefEL (25 chatters)
- WGAG Radio (21 chatters)
- churchfolk (21 chatters)
- Indie Intertube Radio (13 chatters)
- Jay King Network (11 chatters)
- Robert Phoenix (7 chatters)
- Heavenly World Network (5 chatters)
- Star Nations Radio Network (4 chatters)
- Tracey and Friends (4 chatters)
- Alana Reign (3 chatters)
- Earth Angels Radio (2 chatters)
- Ilumine Ao (2 chatters)
- Salvation In Jesus Ministry (2 chatters)
- Soul Joy Happiness with Teresa (1 chatters)
- hollischapmanshow (1 chatters)
- TalkSouthRadio (1 chatters)
- Business Credit Radio (1 chatters)
- Life Lessons with Dr Michelle (1 chatters)
- MASTERTEACHER33 (1 chatters)
- PAGE Media Project (1 chatters)
- Rick Sterling (1 chatters)